GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » C-Mer Eye Care Holdings Ltd (HKSE:03309) » Definitions » Altman Z-Score

C-Mer Eye Care Holdings (HKSE:03309) Altman Z-Score : 3.93 (As of Jun. 07, 2024)


View and export this data going back to 2018. Start your Free Trial

What is C-Mer Eye Care Holdings Altman Z-Score?

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Good Sign:

Altman Z-score of 4 is strong.

C-Mer Eye Care Holdings has a Altman Z-Score of 3.93, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for C-Mer Eye Care Holdings's Altman Z-Score or its related term are showing as below:

HKSE:03309' s Altman Z-Score Range Over the Past 10 Years
Min: 4   Med: 10.66   Max: 60.56
Current: 4

During the past 10 years, C-Mer Eye Care Holdings's highest Altman Z-Score was 60.56. The lowest was 4.00. And the median was 10.66.


C-Mer Eye Care Holdings Altman Z-Score Historical Data

The historical data trend for C-Mer Eye Care Holdings's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C-Mer Eye Care Holdings Altman Z-Score Chart

C-Mer Eye Care Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Altman Z-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.51 12.74 8.57 4.85 4.49

C-Mer Eye Care Holdings Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Altman Z-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.57 - 4.85 - 4.49

Competitive Comparison of C-Mer Eye Care Holdings's Altman Z-Score

For the Medical Care Facilities subindustry, C-Mer Eye Care Holdings's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


C-Mer Eye Care Holdings's Altman Z-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, C-Mer Eye Care Holdings's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where C-Mer Eye Care Holdings's Altman Z-Score falls into.



C-Mer Eye Care Holdings Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

C-Mer Eye Care Holdings's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*0.1204+1.4*0.0281+3.3*0.0518+0.6*4.7872+1.0*0.7
=3.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Dec. 2023:
Total Assets was HK$2,749 Mil.
Total Current Assets was HK$720 Mil.
Total Current Liabilities was HK$389 Mil.
Retained Earnings was HK$77 Mil.
Pre-Tax Income was HK$124 Mil.
Interest Expense was HK$-18 Mil.
Revenue was HK$1,924 Mil.
Market Cap (Today) was HK$3,616 Mil.
Total Liabilities was HK$755 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(720.135 - 389.325)/2748.635
=0.1204

X2=Retained Earnings/Total Assets
=77.365/2748.635
=0.0281

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(124.269 - -18.122)/2748.635
=0.0518

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=3616.015/755.349
=4.7872

X5=Revenue/Total Assets
=1923.964/2748.635
=0.7

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

C-Mer Eye Care Holdings has a Altman Z-Score of 3.93 indicating it is in Safe Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.


C-Mer Eye Care Holdings  (HKSE:03309) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


C-Mer Eye Care Holdings Altman Z-Score Related Terms

Thank you for viewing the detailed overview of C-Mer Eye Care Holdings's Altman Z-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


C-Mer Eye Care Holdings (HKSE:03309) Business Description

Traded in Other Exchanges
N/A
Address
1-3 Pedder Street, Suite 1335, Central Building, Central, Hong Kong, HKG
C-Mer Eye Care Holdings Ltd provides general medical and surgical hospital services. It provides ophthalmic health care, diagnosis, treatment, surgical treatment services, and the sale of vision aid and pharmaceutical products in Hong Kong and the People's Republic of China. The company offers cataract, cornea, and ocular surface diseases, glaucoma, vitreoretinal and macular diseases, other eye diseases diagnosis and treatment services, and Chinese medicine treatment of eye diseases. Its segments include Sales of medical consumables, Mainland China ophthalmic business and Mainland China dental business. It generates a vast majority of its revenue from the provision of the ophthalmic services segment.
Executives
C-mer Group Limited 2101 Beneficial owner
Lam Shun Chiu Dennis 2201 Interest of corporation controlled by you
Li Xiaoting 2201 Interest of corporation controlled by you

C-Mer Eye Care Holdings (HKSE:03309) Headlines

No Headlines